Myeong-Soo Lim
Direttore/Membro del Consiglio presso GEMVAXLINK CO., LTD.
Provenienza dei contatti di primo grado di Myeong-Soo Lim
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Apparel/Footwear Retail | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Myeong-Soo Lim tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
GEMVAX&KAEL CO.,LTD. | Industrial Machinery | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
FLASK CO., LTD. | Electronic Production Equipment | Director/Board Member Director/Board Member Chief Executive Officer | |
Hanyang University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
SAMSUNG PHARM. CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Executive Officer | |
ITEK, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Teloid, Inc. | Chief Executive Officer | ||
CREAS F&C Invest Co., Ltd.
CREAS F&C Invest Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Gemvaxlink Co., Ltd., CREAS F&C Invest Co., Ltd. is a management consulting services provider. The company is based in Seoul, South Korea. The South Korean company was founded in 2017. The CEO is Young-Woon Seo. | Miscellaneous Commercial Services | Chief Executive Officer | |
Samsung Medicos Co., Ltd.
Samsung Medicos Co., Ltd. Specialty StoresRetail Trade Samsung Medicos Co., Ltd. manufactures and sells cosmetics. Its products include cosmetics manufactured in original development and design manufacturing and origianl equipment manufacturing. The company was founded on April 27, 2015 and is headquartered in Hwaseong-si, South Korea. | Specialty Stores | Chief Executive Officer | |
Sungkyunkwan University | College/University | Undergraduate Degree | |
Korea University | College/University | Graduate Degree | |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Gemvax USA, Inc. | Chief Executive Officer | ||
Gemvax AS
Gemvax AS Pharmaceuticals: MajorHealth Technology Part of GemVax & KAEL Co., Ltd., Gemvax AS is a Norwegian peptide-based drug development company that focuses on researching and developing treatments for Alzheimer's disease and prostate hyperplasia. The company is based in Porsgrunn, Norway. The company also develops and sell products such as CA filters and provide investment information. The company was founded by Mona Elisabeth Møller. Gemvax was acquired by VaxOnco, Inc. from Pharmexa A/S on October 30, 2008. | Pharmaceuticals: Major | Director/Board Member | |
Gem & Co. /KR/
Gem & Co. /KR/ Investment ManagersFinance Gem & Co. /KR/ engages in the provision of financial consulting and trading services. The company was founded on September 9, 2004 and is headquartered in Seongnam, South Korea. | Investment Managers | Chief Executive Officer | |
Korea Stem Cell Bank Co., Ltd.
Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Biotechnology | Chief Executive Officer | |
KAEL-GemVax Co., Ltd.
KAEL-GemVax Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of GemVax & KAEL Co., Ltd., KAEL-GemVax Co., Ltd. manufactures bio-pharmaceutical products. The company is based in Seongnam, South Korea. The CEOs of the South Korean company are Gyeong Hee Kim, Sang-Jae Kim, Magnus Moliteus. | Pharmaceuticals: Major | Chief Executive Officer | |
Kwangwoon University | College/University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Corea del Sud | 16 |
Stati Uniti | 3 |
Svezia | 2 |
Norvegia | 2 |
Settori
Consumer Services | 5 |
Health Technology | 5 |
Commercial Services | 4 |
Electronic Technology | 3 |
Producer Manufacturing | 2 |
Posizioni
Director/Board Member | 27 |
Chief Executive Officer | 15 |
Undergraduate Degree | 5 |
Corporate Officer/Principal | 4 |
Independent Dir/Board Member | 4 |
Contatti più connessi
Insiders | |
---|---|
Sang-Jae Kim | 14 |
Young-Woon Seo | 7 |
Gi-Woong Kim | 6 |
Jae-Gwon Kim | 4 |
Sang-Jin Jeon | 3 |
Wan-Sang Lee | 3 |
Se-Jin Park | 1 |
Jeong-Il Hwang | 1 |
Sun-Ik Son | 1 |
- Borsa valori
- Insiders
- Myeong-Soo Lim
- Connessioni Società